 Gemcitabine |
| Galanthamine |
| 2-Bromo-5-hydroxy-4-methoxybenzoic acid |
| Taxol side chain |
| N-Benzoyl-(2R,3S)-3-phenylisoserine |
| 4-(2-METHYLAMINO-ETHYL)-PHENOL |
| 4-(2-BROMOETHYL)PHENOL |
| Bortezomib |
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate |
| (9H-Fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate |
| Ethyl N-(diphenylmethylene)glycinate |
| Ezetimibe |
| (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone |
| (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one |
| Vilazodone |
|
| Products |
Cas No. |
Purity |
| Gemcitabine | 122111-11-9 | 99% |
| Gemcitabine | 134790-39-9 | 98% |
| Gemcitabine | 95058-81-4 | 98% |
| Gemcitabine | 122111-03-9 | 99.5% |
| Galanthamine | 357-70-0 | 97% |
| 2-Bromo-5-hydroxy-4-methoxybenzoic acid | 121936-68-3 | 98% |
| Taxol side chain | 132201-32-2 | 99% |
| N-Benzoyl-(2R,3S)-3-phenylisoserine | 132201-33-3 | 99% |
| Taxol side chain | 196404-55-4 | 99% |
| 4-(2-METHYLAMINO-ETHYL)-PHENOL | 370-98-9 | 98% |
| 4-(2-BROMOETHYL)PHENOL | 14140-15-9 | 98% |
| Bortezomib | 179324-69-7 | 99.8% |
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate | 179324-87-9 | 99% |
| (9H-Fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate | 239088-22-3 | 99% |
| Ethyl N-(diphenylmethylene)glycinate | 69555-14-2 | 99% |
|
|
